RN7SL559P

Across TCGA pan-cancer cohorts, RN7SL559P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RN7SL559P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RN7SL559P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL559P expression acts as an unfavorable survival marker, although some lineages such as BLCA and KIRC show a favorable association.

LUSC, READ, and MESO are the cancer types where RN7SL559P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.313	0.460	.006	42	view →
READ	DFS	Median	III,IV	0.509	0.872	.003	28	view →
MESO	DFS	Quartile	IV	0.087	0.382	<.001	24	view →
BLCA	OS	Tertile	III,IV	0.728	0.620	.020	19	view →
OV	DFS	Tertile	IV	0.349	0.603	.011	18	view →
KIRC	DFS	Median	II,III,IV	0.832	0.738	.014	14	view →
HNSC	OS	Median	III,IV	0.390	0.637	.010	13	view →
UVM	DFS	Median	All	0.374	0.634	.041	12	view →
LUAD	DFS	Median	IV	0.406	0.817	.007	12	view →
STAD	OS	Tertile	II,III,IV	0.705	0.405	.030	8	view →
BRCA	DFS	Median	All	0.434	0.586	.021	6	view →
SKCM	OS	Tertile	II,III,IV	0.898	0.835	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RN7SL559P–LUSC (OS)

Open the LUSC breakdown →